{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:43:11Z","timestamp":1790757791561,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.humimm.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T07:59:43Z","timestamp":1601971183000},"page":"663-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The utility of second single antigen bead assay: Clearing the water or stirring up mud?"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-7168","authenticated-orcid":false,"given":"Harold C.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Krummey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-2752","authenticated-orcid":false,"given":"Howard M.","family":"Gebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2020.09.002_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA) the new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0010","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: the Emory algorithm","volume":"6","author":"Bray","year":"2006","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0015","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0b013e318191404c","article-title":"A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation","volume":"86","author":"Bingaman","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.09.002_b0020","article-title":"The virtual crossmatch: an essential tool for transplanting sensitized patients","volume":"131","author":"Jackson","year":"2014","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MOT.0b013e328331c169","article-title":"Utility of the virtual crossmatch in solid organ transplantation","volume":"14","author":"Amico","year":"2009","journal-title":"Curr. Opin. Organ. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humimm.2016.10.002","article-title":"The coordination of allocation: logistics of kidney organ allocation to highly sensitized patients","volume":"78","author":"Lunz","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.09.002_b0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.13606","article-title":"Renal transplantation with final allocation based on the virtual crossmatch","volume":"16","author":"Johnson","year":"2016","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0040","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/trf.12064","article-title":"Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay","volume":"53","author":"Gandhi","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2020.09.002_b0045","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0050","doi-asserted-by":"crossref","unstructured":"Ellis TM. Interpretation of HLA single antigen bead assays. Transpl. Rev (Orlando) 2013;27:108 (why not replace this with our own-Do not rely on MFI paper?).","DOI":"10.1016\/j.trre.2013.07.001"},{"key":"10.1016\/j.humimm.2020.09.002_b0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humimm.2017.05.007","article-title":"Understanding solid-phase HLA antibody assays and the value of MFI","volume":"78","author":"Sullivan","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.09.002_b0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2013a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.09.002_b0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/TP.0b013e318199c581","article-title":"Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies","volume":"87","author":"Kosmoliaptsis","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.09.002_b0070","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.humimm.2013.06.035","article-title":"Antibodies against denatured HLA class II molecules detected in luminex-single antigen assay","volume":"74","author":"Grenzi","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.09.002_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2019.12.006","article-title":"Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing","author":"Dean","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.09.002_b0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cei.12127","article-title":"The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation","volume":"173","author":"Otten","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2020.09.002_b0085","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0000000000000229","article-title":"Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients prevalence, relevance, and impact on organ allocation","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.09.002_b0090","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.09.002_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.humimm.2012.07.064","article-title":"32-OR: are all anti-HLA-Cw antibodies detected with Luminex single antigen bead real antibodies?","volume":"73","author":"Xu","year":"2012","journal-title":"Human Immunology"},{"key":"10.1016\/j.humimm.2020.09.002_b0100","doi-asserted-by":"crossref","unstructured":"C.K. Breitenbach, L. Chapman, P. Gebel, H.M. Bray, R.A., Pretreatment of patient serum with fetal bovine serum (FBS) reduces non-specific background and enhances HLA antibody detection in bead and cell based assays. Hum. Imunol. 74 (2013) 74\u201357 (I believe there is a full paper descibing this rather than the absract treferred to here).","DOI":"10.1016\/j.humimm.2013.08.083"},{"key":"10.1016\/j.humimm.2020.09.002_b0105","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/ajt.13650","article-title":"Complement interference is not the same as a prozone phenomenon","volume":"16","author":"Berth","year":"2016","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.humimm.2020.09.002_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000734","article-title":"comparative assessment of anti-HLA antibodies using two commercially available Luminex-based assays","volume":"3","author":"Clerkin","year":"2017","journal-title":"Transpl. Direct"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920303931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920303931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:53:10Z","timestamp":1759319590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885920303931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0198885920303931"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.09.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of second single antigen bead assay: Clearing the water or stirring up mud?","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}